Inhibitory effects of lapachol derivatives on Epstein-Barr virus activation

被引：78
|
作者：
Sacau, EP
Estévez-Braun, A
Ravelo, AG
Ferro, EA
Tokuda, H
Mukainaka, T
Nishino, H
机构：
[1] Univ La Laguna, Inst Univ Bioorgan Antonio Gonzalez, E-38206 Tenerife, Spain
[2] Kyoto Prefectural Univ Med, Dept Biochem, Kyoto 602, Japan
[3] Univ Asuncion, Dept Fitoquim, Asuncion, Paraguay
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2003年 / 11卷 / 04期
关键词：
D O I：
10.1016/S0968-0896(02)00542-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Sixteen derivatives (2-17) synthesized from the naphthoquinone lapachol (1), were tested for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), as a test for potential cancer chemopreventive agents. They exhibited a variety of inhibitory activities from very high to moderate, which allow us to suggest structure-activity relationships. Ten of these derivatives are reported for the first time, their structures being thoroughly determined by spectroscopic methods. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：483 / 488
页数：6
相关论文
共 50 条
  • [1] Inhibitory effects of quassinoid derivatives on Epstein-Barr virus early antigen activation
    Rahman, S
    Fukamiya, N
    Ohno, N
    Tokuda, H
    Nishino, H
    Tagahara, K
    Lee, KH
    Okano, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (04) : 675 - 677
  • [2] Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation
    Koyama, J
    Morita, I
    Tagahara, K
    Ogata, M
    Mukainaka, T
    Tokuda, H
    Nishino, H
    CANCER LETTERS, 2001, 170 (01) : 15 - 18
  • [3] Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives
    Koyama, Junko
    Inoue, Munetaka
    Morita, Izumi
    Kobayashi, Norihiro
    Osakai, Toshiyuki
    Nishino, Hoyoku
    Tokuda, Harukuni
    CANCER LETTERS, 2006, 241 (02) : 263 - 267
  • [4] Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation
    Inada, A
    Nakanishi, T
    Tokuda, H
    Nishina, H
    Iwashima, A
    Sharma, OP
    PLANTA MEDICA, 1995, 61 (06) : 558 - 559
  • [5] Inhibitory effects on Epstein-Barr virus activation of anthraquinones: Correlation with redox potentials
    Koyama, J
    Tagahara, K
    Osakai, T
    Tsujino, Y
    Tsurumi, S
    Nishino, H
    Tokuda, H
    CANCER LETTERS, 1997, 115 (02) : 179 - 183
  • [6] Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones
    Koyama, J
    Morita, I
    Tagahara, K
    Osakai, T
    Hotta, H
    Yang, MX
    Mukainaka, T
    Nishino, H
    Tokuda, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (09) : 1214 - 1216
  • [7] Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products
    Akihisa, T
    Hamasaki, Y
    Tokuda, H
    Ukiya, M
    Kimura, Y
    Nishino, H
    JOURNAL OF NATURAL PRODUCTS, 2004, 67 (03): : 407 - 410
  • [8] Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation
    Uesato, S
    Taniuchi, K
    Kumagai, A
    Nagaoka, Y
    Seto, R
    Hara, Y
    Tokuda, H
    Nishino, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (12) : 1448 - 1450
  • [9] Correlation between oxidation potentials and inhibitory effects on Epstein-Barr virus activation of flavonoids
    Koyama, Junko
    Morita, Izumi
    Kobayashi, Norihiro
    Konoshima, Takao
    Takasaki, Midori
    Osakai, Toshiyuki
    Tokuda, Harukuni
    CANCER LETTERS, 2008, 263 (01) : 61 - 66
  • [10] Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
    Yiu, Ching-Yi
    Chen, Shih-Ying
    Chang, Li-Kwan
    Chiu, Ya-Fang
    Lin, Tsuey-Pin
    MOLECULES, 2010, 15 (10) : 7115 - 7124
12345